Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$429K Hold
1,183
0.01% 207
2026
Q1
$416K Buy
1,183
+1
+0.1% +$356 0.02% 201
2025
Q4
$387K Buy
1,182
+90
+8% +$28.5K 0.01% 212
2025
Q3
$308K Buy
1,092
+235
+27% +$68.2K 0.01% 224
2025
Q2
$239K Buy
857
+4
+0.5% +$1.13K 0.01% 237
2025
Q1
$262K Hold
853
0.01% 217
2024
Q4
$221K Buy
853
+1
+0.1% +$297 0.01% 239
2024
Q3
$275K Hold
852
0.01% 215
2024
Q2
$266K Buy
852
+1
+0.1% +$294 0.01% 208
2024
Q1
$242K Buy
+851
New +$249K 0.01% 196
2020
Q4
Sell
-1,278
Closed -$325K 148
2020
Q3
$325K Sell
1,278
-376
-23% -$93.1K 0.03% 111
2020
Q2
$390K Sell
1,654
-9
-0.5% -$2.05K 0.04% 92
2020
Q1
$337K Buy
1,663
+109
+7% +$23.8K 0.04% 94
2019
Q4
$375K Buy
1,554
+318
+26% +$70.1K 0.04% 85
2019
Q3
$239K Buy
1,236
+59
+5% +$11.3K 0.02% 107
2019
Q2
$217K Sell
1,177
-172
-13% -$30.8K 0.02% 105
2019
Q1
$256K Buy
1,349
+172
+15% +$32.8K 0.03% 108
2018
Q4
$229K Hold
1,177
0.03% 107
2018
Q3
$244 Hold
1,177
0.03% 112
2018
Q2
$217K Hold
1,177
0.03% 107
2018
Q1
$201K Buy
1,177
+325
+38% +$59.7K 0.03% 105
2017
Q4
$148K Buy
+852
New +$151K 0.02% 115
2017
Q3
Sell
-3,713
Closed -$639K 130
2017
Q2
$639K Buy
+3,713
New +$604K 0.11% 62

Other funds holding AMGN

Welch Group's AMGN Position: Q2 2026 in Review

Welch Group held its Amgen (AMGN) position steady in Q2 2026 at 1,183 shares worth $429K. The position accounts for 0.01% of the portfolio, ranked #207.

Welch Group first reported a position in AMGN in Q2 2017 and has held it in 23 quarters since. The position peaked at $639K in Q2 2017. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Welch Group held 1,183 shares of Amgen worth $429K as of Q2 2026.
  • Welch Group left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.01% of Welch Group's portfolio in Q2 2026, its #207 holding.
  • Welch Group first reported a position in Amgen in Q2 2017 and has held it in 23 quarters since.
  • Welch Group's Amgen position peaked at $639K in Q2 2017.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Welch Group's 13F filing for Q2 2026, filed 23 Jul 2026.